{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Part 1 - Importing necessary packages\n",
    "\n",
    "If installation was done correctly, there should be no errors here."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "%matplotlib inline\n",
    "\n",
    "# Numerical library\n",
    "import numpy as np\n",
    "\n",
    "# Data manipulation\n",
    "import pandas as pd\n",
    "from patsy import dmatrix\n",
    "\n",
    "# Ploting\n",
    "import matplotlib\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Survival analysis\n",
    "import lifelines"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Part 2 - A look at the clinical data\n",
    "The data is originally avaliable at http://www.cbioportal.org/study?id=brca_tcga_pub, but it can also be found together with this notebook at https://github.com/gjeuken/survival-workshop.\n",
    "\n",
    "We will use here clinical data on the patients as well as gene expression data. Firstly, lets load the clinical data and see what it looks like. Make a note of all the variables (columns) avaliable in the data."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": false,
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Patient ID</th>\n",
       "      <th>Sample ID</th>\n",
       "      <th>CN Cluster</th>\n",
       "      <th>Cancer Studies</th>\n",
       "      <th>Cancer Type</th>\n",
       "      <th>Cancer Type Detailed</th>\n",
       "      <th>Converted Stage</th>\n",
       "      <th>Diagnosis Age</th>\n",
       "      <th>ER Status</th>\n",
       "      <th>HER2 Status</th>\n",
       "      <th>Integrated Clusters (no exp)</th>\n",
       "      <th>Integrated Clusters (unsup exp)</th>\n",
       "      <th>Integrated Clusters (with PAM50)</th>\n",
       "      <th>MIRNA Cluster</th>\n",
       "      <th>Metastasis</th>\n",
       "      <th>Metastasis-Coded</th>\n",
       "      <th>Methylation Cluster</th>\n",
       "      <th>Node</th>\n",
       "      <th>Node-Coded</th>\n",
       "      <th>Oncotree Code</th>\n",
       "      <th>Overall Survival (Months)</th>\n",
       "      <th>Overall Survival Status</th>\n",
       "      <th>PAM50 subtype</th>\n",
       "      <th>PR Status</th>\n",
       "      <th>RPPA Cluster</th>\n",
       "      <th>Sex</th>\n",
       "      <th>SigClust Intrinsic mRNA</th>\n",
       "      <th>SigClust Unsupervised mRNA</th>\n",
       "      <th>Survival Data Form</th>\n",
       "      <th>Tumor Stage</th>\n",
       "      <th>Tumor--T1 Coded</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>TCGA-A2-A0T2</td>\n",
       "      <td>TCGA-A2-A0T2-01</td>\n",
       "      <td>3.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>No_Conversion</td>\n",
       "      <td>66.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>M1</td>\n",
       "      <td>Positive</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N3</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>7.89</td>\n",
       "      <td>DECEASED</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Basal</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T3</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>TCGA-A2-A04P</td>\n",
       "      <td>TCGA-A2-A04P-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>No_Conversion</td>\n",
       "      <td>36.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N3</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>17.97</td>\n",
       "      <td>DECEASED</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Basal</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>TCGA-A1-A0SK</td>\n",
       "      <td>TCGA-A1-A0SK-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIA</td>\n",
       "      <td>54.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>31.77</td>\n",
       "      <td>DECEASED</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Basal</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>-6.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>TCGA-A2-A0CM</td>\n",
       "      <td>TCGA-A2-A0CM-01</td>\n",
       "      <td>4.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIA</td>\n",
       "      <td>40.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>4.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>24.77</td>\n",
       "      <td>DECEASED</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Basal</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>-12.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>TCGA-AR-A1AR</td>\n",
       "      <td>TCGA-AR-A1AR-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIIA</td>\n",
       "      <td>50.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N2</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>17.18</td>\n",
       "      <td>DECEASED</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>T1</td>\n",
       "      <td>T1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>TCGA-B6-A0WX</td>\n",
       "      <td>TCGA-B6-A0WX-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>No_Conversion</td>\n",
       "      <td>40.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N1</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>21.45</td>\n",
       "      <td>DECEASED</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>X</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T3</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>TCGA-BH-A1F0</td>\n",
       "      <td>TCGA-BH-A1F0-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIA</td>\n",
       "      <td>80.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N1</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>25.79</td>\n",
       "      <td>DECEASED</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Indeterminate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>-12.0</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>T1</td>\n",
       "      <td>T1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>TCGA-B6-A0I6</td>\n",
       "      <td>TCGA-B6-A0I6-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>No_Conversion</td>\n",
       "      <td>49.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N1</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>32.76</td>\n",
       "      <td>DECEASED</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Basal</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T1</td>\n",
       "      <td>T1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>TCGA-BH-A18V</td>\n",
       "      <td>TCGA-BH-A18V-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>No_Conversion</td>\n",
       "      <td>48.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N1</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>51.09</td>\n",
       "      <td>DECEASED</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Basal</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>-12.0</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>TCGA-BH-A18Q</td>\n",
       "      <td>TCGA-BH-A18Q-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>No_Conversion</td>\n",
       "      <td>56.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N1</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>55.59</td>\n",
       "      <td>DECEASED</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Basal</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>-12.0</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>TCGA-BH-A18K</td>\n",
       "      <td>TCGA-BH-A18K-01</td>\n",
       "      <td>2.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage I</td>\n",
       "      <td>46.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>90.75</td>\n",
       "      <td>DECEASED</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>-12.0</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>T1</td>\n",
       "      <td>T1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>TCGA-BH-A0HL</td>\n",
       "      <td>TCGA-BH-A0HL-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>No_Conversion</td>\n",
       "      <td>56.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>3.0</td>\n",
       "      <td>N1</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>2.37</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Positive</td>\n",
       "      <td>LumA/B</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>TCGA-BH-A0E0</td>\n",
       "      <td>TCGA-BH-A0E0-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>No_Conversion</td>\n",
       "      <td>38.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N3</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>4.37</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Basal</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T3</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>TCGA-BH-A0RX</td>\n",
       "      <td>TCGA-BH-A0RX-01</td>\n",
       "      <td>4.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIA</td>\n",
       "      <td>59.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>5.59</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>ReacII</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>-12.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>TCGA-A7-A13D</td>\n",
       "      <td>TCGA-A7-A13D-01</td>\n",
       "      <td>3.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIA</td>\n",
       "      <td>46.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>8.77</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Positive</td>\n",
       "      <td>ReacII</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>TCGA-BH-A0E6</td>\n",
       "      <td>TCGA-BH-A0E6-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage I</td>\n",
       "      <td>69.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>1.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>1.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>9.59</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>ReacI</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T1</td>\n",
       "      <td>T1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>TCGA-AO-A0J4</td>\n",
       "      <td>TCGA-AO-A0J4-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage I</td>\n",
       "      <td>41.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>9.66</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>-12.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T1</td>\n",
       "      <td>T1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>TCGA-A7-A0CE</td>\n",
       "      <td>TCGA-A7-A0CE-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIA</td>\n",
       "      <td>57.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>10.15</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Basal</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>TCGA-A7-A13E</td>\n",
       "      <td>TCGA-A7-A13E-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>No_Conversion</td>\n",
       "      <td>62.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>4.0</td>\n",
       "      <td>N1</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>10.71</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Basal</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>-12.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>TCGA-A7-A0DA</td>\n",
       "      <td>TCGA-A7-A0DA-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIA</td>\n",
       "      <td>62.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>12.25</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>X</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>TCGA-D8-A142</td>\n",
       "      <td>TCGA-D8-A142-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIB</td>\n",
       "      <td>74.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>13.96</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>X</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T3</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>TCGA-D8-A143</td>\n",
       "      <td>TCGA-D8-A143-01</td>\n",
       "      <td>3.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIA</td>\n",
       "      <td>51.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>14.16</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Basal</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>TCGA-AQ-A04J</td>\n",
       "      <td>TCGA-AQ-A04J-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIA</td>\n",
       "      <td>45.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>16.39</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>-12.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>TCGA-BH-A0HN</td>\n",
       "      <td>TCGA-BH-A0HN-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage I</td>\n",
       "      <td>67.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>16.95</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Positive</td>\n",
       "      <td>ReacI</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T1</td>\n",
       "      <td>T1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>TCGA-A2-A0T0</td>\n",
       "      <td>TCGA-A2-A0T0-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>No_Conversion</td>\n",
       "      <td>59.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N1</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>17.51</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Basal</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>TCGA-A2-A0YE</td>\n",
       "      <td>TCGA-A2-A0YE-01</td>\n",
       "      <td>3.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>No_Conversion</td>\n",
       "      <td>48.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N1</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>18.17</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>X</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>-12.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>TCGA-A2-A0YJ</td>\n",
       "      <td>TCGA-A2-A0YJ-01</td>\n",
       "      <td>3.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>No_Conversion</td>\n",
       "      <td>39.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N2</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>18.56</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Basal</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>-12.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T3</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>TCGA-A2-A0D0</td>\n",
       "      <td>TCGA-A2-A0D0-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIA</td>\n",
       "      <td>60.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>21.13</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Basal</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>-12.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>TCGA-A2-A04U</td>\n",
       "      <td>TCGA-A2-A04U-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIA</td>\n",
       "      <td>47.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>22.01</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Basal</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>TCGA-AO-A0J6</td>\n",
       "      <td>TCGA-AO-A0J6-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIA</td>\n",
       "      <td>61.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>25.46</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>Basal-like</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Basal</td>\n",
       "      <td>Female</td>\n",
       "      <td>-13.0</td>\n",
       "      <td>-12.0</td>\n",
       "      <td>followup</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>795</th>\n",
       "      <td>TCGA-EW-A1P7</td>\n",
       "      <td>TCGA-EW-A1P7-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIA</td>\n",
       "      <td>59.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>20.86</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>796</th>\n",
       "      <td>TCGA-EW-A1PA</td>\n",
       "      <td>TCGA-EW-A1PA-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIB</td>\n",
       "      <td>59.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>4.0</td>\n",
       "      <td>N1</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>8.77</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>797</th>\n",
       "      <td>TCGA-EW-A1PB</td>\n",
       "      <td>TCGA-EW-A1PB-01</td>\n",
       "      <td>3.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIIA</td>\n",
       "      <td>70.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N1</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>19.98</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>T3</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>798</th>\n",
       "      <td>TCGA-EW-A1PD</td>\n",
       "      <td>TCGA-EW-A1PD-01</td>\n",
       "      <td>5.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIA</td>\n",
       "      <td>61.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>2.0</td>\n",
       "      <td>N1</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>5.72</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Male</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>T1</td>\n",
       "      <td>T1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>799</th>\n",
       "      <td>TCGA-EW-A1PE</td>\n",
       "      <td>TCGA-EW-A1PE-01</td>\n",
       "      <td>2.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIA</td>\n",
       "      <td>56.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>1.0</td>\n",
       "      <td>N1</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>4.57</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>T1</td>\n",
       "      <td>T1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>800</th>\n",
       "      <td>TCGA-EW-A1PF</td>\n",
       "      <td>TCGA-EW-A1PF-01</td>\n",
       "      <td>5.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage I</td>\n",
       "      <td>50.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>1.0</td>\n",
       "      <td>N0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>4.57</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>T1</td>\n",
       "      <td>T1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>801</th>\n",
       "      <td>TCGA-EW-A1PG</td>\n",
       "      <td>TCGA-EW-A1PG-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIB</td>\n",
       "      <td>53.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>1.0</td>\n",
       "      <td>N1</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>28.75</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>T2</td>\n",
       "      <td>T_Other</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>802</th>\n",
       "      <td>TCGA-EW-A1PH</td>\n",
       "      <td>TCGA-EW-A1PH-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>Stage IIA</td>\n",
       "      <td>52.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5.0</td>\n",
       "      <td>M0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>5.0</td>\n",
       "      <td>N1</td>\n",
       "      <td>Positive</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>4.57</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>T1</td>\n",
       "      <td>T1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>803</th>\n",
       "      <td>TCGA-EW-A2FS</td>\n",
       "      <td>TCGA-EW-A2FS-01</td>\n",
       "      <td>5.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>41.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>38.54</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>804</th>\n",
       "      <td>TCGA-EW-A2FV</td>\n",
       "      <td>TCGA-EW-A2FV-01</td>\n",
       "      <td>3.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>39.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>7.82</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805</th>\n",
       "      <td>TCGA-EW-A2FW</td>\n",
       "      <td>TCGA-EW-A2FW-01</td>\n",
       "      <td>3.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>52.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>6.24</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>806</th>\n",
       "      <td>TCGA-GM-A2DA</td>\n",
       "      <td>TCGA-GM-A2DA-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>46.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>194.14</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>807</th>\n",
       "      <td>TCGA-GM-A2DB</td>\n",
       "      <td>TCGA-GM-A2DB-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>62.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>53.06</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>808</th>\n",
       "      <td>TCGA-GM-A2DC</td>\n",
       "      <td>TCGA-GM-A2DC-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>57.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>53.49</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>809</th>\n",
       "      <td>TCGA-GM-A2DD</td>\n",
       "      <td>TCGA-GM-A2DD-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>53.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>43.01</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>810</th>\n",
       "      <td>TCGA-GM-A2DF</td>\n",
       "      <td>TCGA-GM-A2DF-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>53.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>42.68</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>811</th>\n",
       "      <td>TCGA-GM-A2DH</td>\n",
       "      <td>TCGA-GM-A2DH-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>58.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>42.25</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>812</th>\n",
       "      <td>TCGA-GM-A2DI</td>\n",
       "      <td>TCGA-GM-A2DI-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>52.0</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>61.87</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>813</th>\n",
       "      <td>TCGA-GM-A2DK</td>\n",
       "      <td>TCGA-GM-A2DK-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>58.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>62.29</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Negative</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>814</th>\n",
       "      <td>TCGA-GM-A2DL</td>\n",
       "      <td>TCGA-GM-A2DL-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>50.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>90.75</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>815</th>\n",
       "      <td>TCGA-GM-A2DM</td>\n",
       "      <td>TCGA-GM-A2DM-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>57.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>76.58</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>816</th>\n",
       "      <td>TCGA-GM-A2DN</td>\n",
       "      <td>TCGA-GM-A2DN-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>58.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>77.27</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>817</th>\n",
       "      <td>TCGA-GM-A2DO</td>\n",
       "      <td>TCGA-GM-A2DO-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>54.0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>53.29</td>\n",
       "      <td>LIVING</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Positive</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Female</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>enrollment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>818</th>\n",
       "      <td>TCGA-AR-A24W</td>\n",
       "      <td>TCGA-AR-A24W-01</td>\n",
       "      <td>3.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>819</th>\n",
       "      <td>TCGA-AC-A2B8</td>\n",
       "      <td>TCGA-AC-A2B8-01</td>\n",
       "      <td>2.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>820</th>\n",
       "      <td>TCGA-AC-A2FF</td>\n",
       "      <td>TCGA-AC-A2FF-01</td>\n",
       "      <td>1.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>821</th>\n",
       "      <td>TCGA-AC-A2FB</td>\n",
       "      <td>TCGA-AC-A2FB-01</td>\n",
       "      <td>3.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>822</th>\n",
       "      <td>TCGA-AC-A2FG</td>\n",
       "      <td>TCGA-AC-A2FG-01</td>\n",
       "      <td>2.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>823</th>\n",
       "      <td>TCGA-GI-A2C8</td>\n",
       "      <td>TCGA-GI-A2C8-01</td>\n",
       "      <td>3.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>824</th>\n",
       "      <td>TCGA-E9-A295</td>\n",
       "      <td>TCGA-E9-A295-01</td>\n",
       "      <td>3.0</td>\n",
       "      <td>brca_tcga_pub</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Invasive Breast Carcinoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>825 rows  31 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       Patient ID        Sample ID  CN Cluster Cancer Studies    Cancer Type  \\\n",
       "0    TCGA-A2-A0T2  TCGA-A2-A0T2-01         3.0  brca_tcga_pub  Breast Cancer   \n",
       "1    TCGA-A2-A04P  TCGA-A2-A04P-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "2    TCGA-A1-A0SK  TCGA-A1-A0SK-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "3    TCGA-A2-A0CM  TCGA-A2-A0CM-01         4.0  brca_tcga_pub  Breast Cancer   \n",
       "4    TCGA-AR-A1AR  TCGA-AR-A1AR-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "5    TCGA-B6-A0WX  TCGA-B6-A0WX-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "6    TCGA-BH-A1F0  TCGA-BH-A1F0-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "7    TCGA-B6-A0I6  TCGA-B6-A0I6-01         NaN  brca_tcga_pub  Breast Cancer   \n",
       "8    TCGA-BH-A18V  TCGA-BH-A18V-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "9    TCGA-BH-A18Q  TCGA-BH-A18Q-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "10   TCGA-BH-A18K  TCGA-BH-A18K-01         2.0  brca_tcga_pub  Breast Cancer   \n",
       "11   TCGA-BH-A0HL  TCGA-BH-A0HL-01         NaN  brca_tcga_pub  Breast Cancer   \n",
       "12   TCGA-BH-A0E0  TCGA-BH-A0E0-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "13   TCGA-BH-A0RX  TCGA-BH-A0RX-01         4.0  brca_tcga_pub  Breast Cancer   \n",
       "14   TCGA-A7-A13D  TCGA-A7-A13D-01         3.0  brca_tcga_pub  Breast Cancer   \n",
       "15   TCGA-BH-A0E6  TCGA-BH-A0E6-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "16   TCGA-AO-A0J4  TCGA-AO-A0J4-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "17   TCGA-A7-A0CE  TCGA-A7-A0CE-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "18   TCGA-A7-A13E  TCGA-A7-A13E-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "19   TCGA-A7-A0DA  TCGA-A7-A0DA-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "20   TCGA-D8-A142  TCGA-D8-A142-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "21   TCGA-D8-A143  TCGA-D8-A143-01         3.0  brca_tcga_pub  Breast Cancer   \n",
       "22   TCGA-AQ-A04J  TCGA-AQ-A04J-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "23   TCGA-BH-A0HN  TCGA-BH-A0HN-01         NaN  brca_tcga_pub  Breast Cancer   \n",
       "24   TCGA-A2-A0T0  TCGA-A2-A0T0-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "25   TCGA-A2-A0YE  TCGA-A2-A0YE-01         3.0  brca_tcga_pub  Breast Cancer   \n",
       "26   TCGA-A2-A0YJ  TCGA-A2-A0YJ-01         3.0  brca_tcga_pub  Breast Cancer   \n",
       "27   TCGA-A2-A0D0  TCGA-A2-A0D0-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "28   TCGA-A2-A04U  TCGA-A2-A04U-01         NaN  brca_tcga_pub  Breast Cancer   \n",
       "29   TCGA-AO-A0J6  TCGA-AO-A0J6-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "..            ...              ...         ...            ...            ...   \n",
       "795  TCGA-EW-A1P7  TCGA-EW-A1P7-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "796  TCGA-EW-A1PA  TCGA-EW-A1PA-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "797  TCGA-EW-A1PB  TCGA-EW-A1PB-01         3.0  brca_tcga_pub  Breast Cancer   \n",
       "798  TCGA-EW-A1PD  TCGA-EW-A1PD-01         5.0  brca_tcga_pub  Breast Cancer   \n",
       "799  TCGA-EW-A1PE  TCGA-EW-A1PE-01         2.0  brca_tcga_pub  Breast Cancer   \n",
       "800  TCGA-EW-A1PF  TCGA-EW-A1PF-01         5.0  brca_tcga_pub  Breast Cancer   \n",
       "801  TCGA-EW-A1PG  TCGA-EW-A1PG-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "802  TCGA-EW-A1PH  TCGA-EW-A1PH-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "803  TCGA-EW-A2FS  TCGA-EW-A2FS-01         5.0  brca_tcga_pub  Breast Cancer   \n",
       "804  TCGA-EW-A2FV  TCGA-EW-A2FV-01         3.0  brca_tcga_pub  Breast Cancer   \n",
       "805  TCGA-EW-A2FW  TCGA-EW-A2FW-01         3.0  brca_tcga_pub  Breast Cancer   \n",
       "806  TCGA-GM-A2DA  TCGA-GM-A2DA-01         NaN  brca_tcga_pub  Breast Cancer   \n",
       "807  TCGA-GM-A2DB  TCGA-GM-A2DB-01         NaN  brca_tcga_pub  Breast Cancer   \n",
       "808  TCGA-GM-A2DC  TCGA-GM-A2DC-01         NaN  brca_tcga_pub  Breast Cancer   \n",
       "809  TCGA-GM-A2DD  TCGA-GM-A2DD-01         NaN  brca_tcga_pub  Breast Cancer   \n",
       "810  TCGA-GM-A2DF  TCGA-GM-A2DF-01         NaN  brca_tcga_pub  Breast Cancer   \n",
       "811  TCGA-GM-A2DH  TCGA-GM-A2DH-01         NaN  brca_tcga_pub  Breast Cancer   \n",
       "812  TCGA-GM-A2DI  TCGA-GM-A2DI-01         NaN  brca_tcga_pub  Breast Cancer   \n",
       "813  TCGA-GM-A2DK  TCGA-GM-A2DK-01         NaN  brca_tcga_pub  Breast Cancer   \n",
       "814  TCGA-GM-A2DL  TCGA-GM-A2DL-01         NaN  brca_tcga_pub  Breast Cancer   \n",
       "815  TCGA-GM-A2DM  TCGA-GM-A2DM-01         NaN  brca_tcga_pub  Breast Cancer   \n",
       "816  TCGA-GM-A2DN  TCGA-GM-A2DN-01         NaN  brca_tcga_pub  Breast Cancer   \n",
       "817  TCGA-GM-A2DO  TCGA-GM-A2DO-01         NaN  brca_tcga_pub  Breast Cancer   \n",
       "818  TCGA-AR-A24W  TCGA-AR-A24W-01         3.0  brca_tcga_pub  Breast Cancer   \n",
       "819  TCGA-AC-A2B8  TCGA-AC-A2B8-01         2.0  brca_tcga_pub  Breast Cancer   \n",
       "820  TCGA-AC-A2FF  TCGA-AC-A2FF-01         1.0  brca_tcga_pub  Breast Cancer   \n",
       "821  TCGA-AC-A2FB  TCGA-AC-A2FB-01         3.0  brca_tcga_pub  Breast Cancer   \n",
       "822  TCGA-AC-A2FG  TCGA-AC-A2FG-01         2.0  brca_tcga_pub  Breast Cancer   \n",
       "823  TCGA-GI-A2C8  TCGA-GI-A2C8-01         3.0  brca_tcga_pub  Breast Cancer   \n",
       "824  TCGA-E9-A295  TCGA-E9-A295-01         3.0  brca_tcga_pub  Breast Cancer   \n",
       "\n",
       "          Cancer Type Detailed Converted Stage  Diagnosis Age ER Status  \\\n",
       "0    Invasive Breast Carcinoma   No_Conversion           66.0  Negative   \n",
       "1    Invasive Breast Carcinoma   No_Conversion           36.0  Negative   \n",
       "2    Invasive Breast Carcinoma       Stage IIA           54.0  Negative   \n",
       "3    Invasive Breast Carcinoma       Stage IIA           40.0  Negative   \n",
       "4    Invasive Breast Carcinoma      Stage IIIA           50.0  Negative   \n",
       "5    Invasive Breast Carcinoma   No_Conversion           40.0  Negative   \n",
       "6    Invasive Breast Carcinoma       Stage IIA           80.0  Negative   \n",
       "7    Invasive Breast Carcinoma   No_Conversion           49.0  Negative   \n",
       "8    Invasive Breast Carcinoma   No_Conversion           48.0  Negative   \n",
       "9    Invasive Breast Carcinoma   No_Conversion           56.0  Negative   \n",
       "10   Invasive Breast Carcinoma         Stage I           46.0  Positive   \n",
       "11   Invasive Breast Carcinoma   No_Conversion           56.0  Positive   \n",
       "12   Invasive Breast Carcinoma   No_Conversion           38.0  Negative   \n",
       "13   Invasive Breast Carcinoma       Stage IIA           59.0  Negative   \n",
       "14   Invasive Breast Carcinoma       Stage IIA           46.0  Negative   \n",
       "15   Invasive Breast Carcinoma         Stage I           69.0  Negative   \n",
       "16   Invasive Breast Carcinoma         Stage I           41.0  Negative   \n",
       "17   Invasive Breast Carcinoma       Stage IIA           57.0  Negative   \n",
       "18   Invasive Breast Carcinoma   No_Conversion           62.0  Positive   \n",
       "19   Invasive Breast Carcinoma       Stage IIA           62.0  Negative   \n",
       "20   Invasive Breast Carcinoma       Stage IIB           74.0  Negative   \n",
       "21   Invasive Breast Carcinoma       Stage IIA           51.0  Negative   \n",
       "22   Invasive Breast Carcinoma       Stage IIA           45.0  Negative   \n",
       "23   Invasive Breast Carcinoma         Stage I           67.0  Positive   \n",
       "24   Invasive Breast Carcinoma   No_Conversion           59.0  Negative   \n",
       "25   Invasive Breast Carcinoma   No_Conversion           48.0  Negative   \n",
       "26   Invasive Breast Carcinoma   No_Conversion           39.0  Positive   \n",
       "27   Invasive Breast Carcinoma       Stage IIA           60.0  Negative   \n",
       "28   Invasive Breast Carcinoma       Stage IIA           47.0  Negative   \n",
       "29   Invasive Breast Carcinoma       Stage IIA           61.0  Negative   \n",
       "..                         ...             ...            ...       ...   \n",
       "795  Invasive Breast Carcinoma       Stage IIA           59.0  Negative   \n",
       "796  Invasive Breast Carcinoma       Stage IIB           59.0  Positive   \n",
       "797  Invasive Breast Carcinoma      Stage IIIA           70.0  Negative   \n",
       "798  Invasive Breast Carcinoma       Stage IIA           61.0  Positive   \n",
       "799  Invasive Breast Carcinoma       Stage IIA           56.0  Positive   \n",
       "800  Invasive Breast Carcinoma         Stage I           50.0  Positive   \n",
       "801  Invasive Breast Carcinoma       Stage IIB           53.0  Positive   \n",
       "802  Invasive Breast Carcinoma       Stage IIA           52.0  Negative   \n",
       "803  Invasive Breast Carcinoma             NaN           41.0  Positive   \n",
       "804  Invasive Breast Carcinoma             NaN           39.0  Positive   \n",
       "805  Invasive Breast Carcinoma             NaN           52.0  Positive   \n",
       "806  Invasive Breast Carcinoma             NaN           46.0  Positive   \n",
       "807  Invasive Breast Carcinoma             NaN           62.0  Negative   \n",
       "808  Invasive Breast Carcinoma             NaN           57.0  Positive   \n",
       "809  Invasive Breast Carcinoma             NaN           53.0  Negative   \n",
       "810  Invasive Breast Carcinoma             NaN           53.0  Negative   \n",
       "811  Invasive Breast Carcinoma             NaN           58.0  Negative   \n",
       "812  Invasive Breast Carcinoma             NaN           52.0  Negative   \n",
       "813  Invasive Breast Carcinoma             NaN           58.0  Positive   \n",
       "814  Invasive Breast Carcinoma             NaN           50.0  Positive   \n",
       "815  Invasive Breast Carcinoma             NaN           57.0  Positive   \n",
       "816  Invasive Breast Carcinoma             NaN           58.0  Positive   \n",
       "817  Invasive Breast Carcinoma             NaN           54.0  Positive   \n",
       "818  Invasive Breast Carcinoma             NaN            NaN       NaN   \n",
       "819  Invasive Breast Carcinoma             NaN            NaN       NaN   \n",
       "820  Invasive Breast Carcinoma             NaN            NaN       NaN   \n",
       "821  Invasive Breast Carcinoma             NaN            NaN       NaN   \n",
       "822  Invasive Breast Carcinoma             NaN            NaN       NaN   \n",
       "823  Invasive Breast Carcinoma             NaN            NaN       NaN   \n",
       "824  Invasive Breast Carcinoma             NaN            NaN       NaN   \n",
       "\n",
       "    HER2 Status  Integrated Clusters (no exp)  \\\n",
       "0      Negative                           2.0   \n",
       "1      Negative                           2.0   \n",
       "2      Negative                           2.0   \n",
       "3      Negative                           1.0   \n",
       "4      Negative                           NaN   \n",
       "5      Negative                           2.0   \n",
       "6      Negative                           NaN   \n",
       "7           NaN                           NaN   \n",
       "8      Negative                           2.0   \n",
       "9      Negative                           2.0   \n",
       "10     Negative                           NaN   \n",
       "11     Negative                           NaN   \n",
       "12     Negative                           2.0   \n",
       "13     Negative                           3.0   \n",
       "14     Negative                           2.0   \n",
       "15     Negative                           1.0   \n",
       "16     Negative                           NaN   \n",
       "17     Negative                           2.0   \n",
       "18     Negative                           NaN   \n",
       "19     Negative                           2.0   \n",
       "20     Negative                           2.0   \n",
       "21     Negative                           NaN   \n",
       "22     Negative                           NaN   \n",
       "23     Negative                           NaN   \n",
       "24     Negative                           2.0   \n",
       "25     Negative                           NaN   \n",
       "26     Negative                           NaN   \n",
       "27     Negative                           2.0   \n",
       "28     Negative                           NaN   \n",
       "29     Negative                           2.0   \n",
       "..          ...                           ...   \n",
       "795    Negative                           NaN   \n",
       "796    Negative                           NaN   \n",
       "797    Negative                           NaN   \n",
       "798    Positive                           NaN   \n",
       "799    Negative                           NaN   \n",
       "800    Negative                           NaN   \n",
       "801    Negative                           NaN   \n",
       "802         NaN                           NaN   \n",
       "803         NaN                           NaN   \n",
       "804         NaN                           NaN   \n",
       "805         NaN                           NaN   \n",
       "806         NaN                           NaN   \n",
       "807         NaN                           NaN   \n",
       "808         NaN                           NaN   \n",
       "809         NaN                           NaN   \n",
       "810         NaN                           NaN   \n",
       "811         NaN                           NaN   \n",
       "812         NaN                           NaN   \n",
       "813         NaN                           NaN   \n",
       "814         NaN                           NaN   \n",
       "815         NaN                           NaN   \n",
       "816         NaN                           NaN   \n",
       "817         NaN                           NaN   \n",
       "818         NaN                           NaN   \n",
       "819         NaN                           NaN   \n",
       "820         NaN                           NaN   \n",
       "821         NaN                           NaN   \n",
       "822         NaN                           NaN   \n",
       "823         NaN                           NaN   \n",
       "824         NaN                           NaN   \n",
       "\n",
       "     Integrated Clusters (unsup exp)  Integrated Clusters (with PAM50)  \\\n",
       "0                                2.0                               2.0   \n",
       "1                                2.0                               2.0   \n",
       "2                                2.0                               2.0   \n",
       "3                                1.0                               2.0   \n",
       "4                                NaN                               NaN   \n",
       "5                                2.0                               2.0   \n",
       "6                                NaN                               NaN   \n",
       "7                                NaN                               NaN   \n",
       "8                                2.0                               2.0   \n",
       "9                                2.0                               2.0   \n",
       "10                               NaN                               NaN   \n",
       "11                               NaN                               NaN   \n",
       "12                               2.0                               2.0   \n",
       "13                               2.0                               2.0   \n",
       "14                               2.0                               2.0   \n",
       "15                               4.0                               3.0   \n",
       "16                               NaN                               NaN   \n",
       "17                               2.0                               2.0   \n",
       "18                               NaN                               NaN   \n",
       "19                               2.0                               2.0   \n",
       "20                               2.0                               2.0   \n",
       "21                               NaN                               NaN   \n",
       "22                               NaN                               NaN   \n",
       "23                               NaN                               NaN   \n",
       "24                               2.0                               2.0   \n",
       "25                               NaN                               NaN   \n",
       "26                               NaN                               NaN   \n",
       "27                               2.0                               2.0   \n",
       "28                               NaN                               NaN   \n",
       "29                               2.0                               2.0   \n",
       "..                               ...                               ...   \n",
       "795                              NaN                               NaN   \n",
       "796                              NaN                               NaN   \n",
       "797                              NaN                               NaN   \n",
       "798                              NaN                               NaN   \n",
       "799                              NaN                               NaN   \n",
       "800                              NaN                               NaN   \n",
       "801                              NaN                               NaN   \n",
       "802                              NaN                               NaN   \n",
       "803                              NaN                               NaN   \n",
       "804                              NaN                               NaN   \n",
       "805                              NaN                               NaN   \n",
       "806                              NaN                               NaN   \n",
       "807                              NaN                               NaN   \n",
       "808                              NaN                               NaN   \n",
       "809                              NaN                               NaN   \n",
       "810                              NaN                               NaN   \n",
       "811                              NaN                               NaN   \n",
       "812                              NaN                               NaN   \n",
       "813                              NaN                               NaN   \n",
       "814                              NaN                               NaN   \n",
       "815                              NaN                               NaN   \n",
       "816                              NaN                               NaN   \n",
       "817                              NaN                               NaN   \n",
       "818                              NaN                               NaN   \n",
       "819                              NaN                               NaN   \n",
       "820                              NaN                               NaN   \n",
       "821                              NaN                               NaN   \n",
       "822                              NaN                               NaN   \n",
       "823                              NaN                               NaN   \n",
       "824                              NaN                               NaN   \n",
       "\n",
       "     MIRNA Cluster Metastasis Metastasis-Coded  Methylation Cluster Node  \\\n",
       "0              3.0         M1         Positive                  5.0   N3   \n",
       "1              5.0         M0         Negative                  5.0   N3   \n",
       "2              5.0         M0         Negative                  5.0   N0   \n",
       "3              4.0         M0         Negative                  4.0   N0   \n",
       "4              5.0         M0         Negative                  5.0   N2   \n",
       "5              4.0         M0         Negative                  5.0   N1   \n",
       "6              6.0         M0         Negative                  5.0   N1   \n",
       "7              4.0         M0         Negative                  5.0   N1   \n",
       "8              5.0         M0         Negative                  5.0   N1   \n",
       "9              5.0         M0         Negative                  5.0   N1   \n",
       "10             5.0         M0         Negative                  2.0   N0   \n",
       "11             4.0         M0         Negative                  3.0   N1   \n",
       "12             5.0         M0         Negative                  5.0   N3   \n",
       "13             4.0         M0         Negative                  5.0   N0   \n",
       "14             5.0         M0         Negative                  5.0   N0   \n",
       "15             4.0         M0         Negative                  1.0   N0   \n",
       "16             4.0         M0         Negative                  5.0   N0   \n",
       "17             5.0         M0         Negative                  5.0   N0   \n",
       "18             5.0         M0         Negative                  4.0   N1   \n",
       "19             4.0         M0         Negative                  5.0   N0   \n",
       "20             3.0         M0         Negative                  5.0   N0   \n",
       "21             NaN         M0         Negative                  5.0   N0   \n",
       "22             4.0         M0         Negative                  5.0   N0   \n",
       "23             6.0         M0         Negative                  2.0   N0   \n",
       "24             5.0         M0         Negative                  5.0   N1   \n",
       "25             NaN         M0         Negative                  5.0   N1   \n",
       "26             NaN         M0         Negative                  5.0   N2   \n",
       "27             5.0         M0         Negative                  5.0   N0   \n",
       "28             5.0         M0         Negative                  5.0   N0   \n",
       "29             2.0         M0         Negative                  5.0   N0   \n",
       "..             ...        ...              ...                  ...  ...   \n",
       "795            3.0         M0         Negative                  5.0   N0   \n",
       "796            NaN         M0         Negative                  4.0   N1   \n",
       "797            2.0         M0         Negative                  5.0   N1   \n",
       "798            4.0         M0         Negative                  2.0   N1   \n",
       "799            3.0         M0         Negative                  1.0   N1   \n",
       "800            4.0         M0         Negative                  1.0   N0   \n",
       "801            6.0         M0         Negative                  1.0   N1   \n",
       "802            5.0         M0         Negative                  5.0   N1   \n",
       "803            NaN        NaN              NaN                  4.0  NaN   \n",
       "804            NaN        NaN              NaN                  4.0  NaN   \n",
       "805            NaN        NaN              NaN                  2.0  NaN   \n",
       "806            NaN        NaN              NaN                  NaN  NaN   \n",
       "807            NaN        NaN              NaN                  NaN  NaN   \n",
       "808            NaN        NaN              NaN                  NaN  NaN   \n",
       "809            NaN        NaN              NaN                  NaN  NaN   \n",
       "810            NaN        NaN              NaN                  NaN  NaN   \n",
       "811            NaN        NaN              NaN                  NaN  NaN   \n",
       "812            NaN        NaN              NaN                  NaN  NaN   \n",
       "813            NaN        NaN              NaN                  NaN  NaN   \n",
       "814            NaN        NaN              NaN                  NaN  NaN   \n",
       "815            NaN        NaN              NaN                  NaN  NaN   \n",
       "816            NaN        NaN              NaN                  NaN  NaN   \n",
       "817            NaN        NaN              NaN                  NaN  NaN   \n",
       "818            6.0        NaN              NaN                  1.0  NaN   \n",
       "819            NaN        NaN              NaN                  1.0  NaN   \n",
       "820            NaN        NaN              NaN                  1.0  NaN   \n",
       "821            NaN        NaN              NaN                  1.0  NaN   \n",
       "822            NaN        NaN              NaN                  1.0  NaN   \n",
       "823            NaN        NaN              NaN                  3.0  NaN   \n",
       "824            NaN        NaN              NaN                  4.0  NaN   \n",
       "\n",
       "    Node-Coded Oncotree Code  Overall Survival (Months)  \\\n",
       "0     Positive          BRCA                       7.89   \n",
       "1     Positive          BRCA                      17.97   \n",
       "2     Negative          BRCA                      31.77   \n",
       "3     Negative          BRCA                      24.77   \n",
       "4     Positive          BRCA                      17.18   \n",
       "5     Positive          BRCA                      21.45   \n",
       "6     Positive          BRCA                      25.79   \n",
       "7     Positive          BRCA                      32.76   \n",
       "8     Positive          BRCA                      51.09   \n",
       "9     Positive          BRCA                      55.59   \n",
       "10    Negative          BRCA                      90.75   \n",
       "11    Positive          BRCA                       2.37   \n",
       "12    Positive          BRCA                       4.37   \n",
       "13    Negative          BRCA                       5.59   \n",
       "14    Negative          BRCA                       8.77   \n",
       "15    Negative          BRCA                       9.59   \n",
       "16    Negative          BRCA                       9.66   \n",
       "17    Negative          BRCA                      10.15   \n",
       "18    Positive          BRCA                      10.71   \n",
       "19    Negative          BRCA                      12.25   \n",
       "20    Negative          BRCA                      13.96   \n",
       "21    Negative          BRCA                      14.16   \n",
       "22    Negative          BRCA                      16.39   \n",
       "23    Negative          BRCA                      16.95   \n",
       "24    Positive          BRCA                      17.51   \n",
       "25    Positive          BRCA                      18.17   \n",
       "26    Positive          BRCA                      18.56   \n",
       "27    Negative          BRCA                      21.13   \n",
       "28    Negative          BRCA                      22.01   \n",
       "29    Negative          BRCA                      25.46   \n",
       "..         ...           ...                        ...   \n",
       "795   Negative          BRCA                      20.86   \n",
       "796   Positive          BRCA                       8.77   \n",
       "797   Positive          BRCA                      19.98   \n",
       "798   Positive          BRCA                       5.72   \n",
       "799   Positive          BRCA                       4.57   \n",
       "800   Negative          BRCA                       4.57   \n",
       "801   Positive          BRCA                      28.75   \n",
       "802   Positive          BRCA                       4.57   \n",
       "803        NaN          BRCA                      38.54   \n",
       "804        NaN          BRCA                       7.82   \n",
       "805        NaN          BRCA                       6.24   \n",
       "806        NaN          BRCA                     194.14   \n",
       "807        NaN          BRCA                      53.06   \n",
       "808        NaN          BRCA                      53.49   \n",
       "809        NaN          BRCA                      43.01   \n",
       "810        NaN          BRCA                      42.68   \n",
       "811        NaN          BRCA                      42.25   \n",
       "812        NaN          BRCA                      61.87   \n",
       "813        NaN          BRCA                      62.29   \n",
       "814        NaN          BRCA                      90.75   \n",
       "815        NaN          BRCA                      76.58   \n",
       "816        NaN          BRCA                      77.27   \n",
       "817        NaN          BRCA                      53.29   \n",
       "818        NaN          BRCA                        NaN   \n",
       "819        NaN          BRCA                        NaN   \n",
       "820        NaN          BRCA                        NaN   \n",
       "821        NaN          BRCA                        NaN   \n",
       "822        NaN          BRCA                        NaN   \n",
       "823        NaN          BRCA                        NaN   \n",
       "824        NaN          BRCA                        NaN   \n",
       "\n",
       "    Overall Survival Status PAM50 subtype      PR Status RPPA Cluster     Sex  \\\n",
       "0                  DECEASED    Basal-like       Negative        Basal  Female   \n",
       "1                  DECEASED    Basal-like       Negative        Basal  Female   \n",
       "2                  DECEASED    Basal-like       Negative        Basal  Female   \n",
       "3                  DECEASED    Basal-like       Negative        Basal  Female   \n",
       "4                  DECEASED    Basal-like       Negative          NaN  Female   \n",
       "5                  DECEASED    Basal-like       Negative            X  Female   \n",
       "6                  DECEASED    Basal-like  Indeterminate          NaN  Female   \n",
       "7                  DECEASED    Basal-like       Negative        Basal  Female   \n",
       "8                  DECEASED    Basal-like       Negative        Basal  Female   \n",
       "9                  DECEASED    Basal-like       Negative        Basal  Female   \n",
       "10                 DECEASED    Basal-like       Positive          NaN  Female   \n",
       "11                   LIVING    Basal-like       Positive       LumA/B  Female   \n",
       "12                   LIVING    Basal-like       Negative        Basal  Female   \n",
       "13                   LIVING    Basal-like       Negative       ReacII  Female   \n",
       "14                   LIVING    Basal-like       Positive       ReacII  Female   \n",
       "15                   LIVING    Basal-like       Negative        ReacI  Female   \n",
       "16                   LIVING    Basal-like       Negative          NaN  Female   \n",
       "17                   LIVING    Basal-like       Negative        Basal  Female   \n",
       "18                   LIVING    Basal-like       Negative        Basal  Female   \n",
       "19                   LIVING    Basal-like       Negative            X  Female   \n",
       "20                   LIVING    Basal-like       Negative            X  Female   \n",
       "21                   LIVING    Basal-like       Negative        Basal  Female   \n",
       "22                   LIVING    Basal-like       Negative          NaN  Female   \n",
       "23                   LIVING    Basal-like       Positive        ReacI  Female   \n",
       "24                   LIVING    Basal-like       Negative        Basal  Female   \n",
       "25                   LIVING    Basal-like       Negative            X  Female   \n",
       "26                   LIVING    Basal-like       Negative        Basal  Female   \n",
       "27                   LIVING    Basal-like       Negative        Basal  Female   \n",
       "28                   LIVING    Basal-like       Negative        Basal  Female   \n",
       "29                   LIVING    Basal-like       Negative        Basal  Female   \n",
       "..                      ...           ...            ...          ...     ...   \n",
       "795                  LIVING           NaN       Negative          NaN  Female   \n",
       "796                  LIVING           NaN       Positive          NaN  Female   \n",
       "797                  LIVING           NaN       Negative          NaN  Female   \n",
       "798                  LIVING           NaN       Positive          NaN    Male   \n",
       "799                  LIVING           NaN       Positive          NaN  Female   \n",
       "800                  LIVING           NaN       Positive          NaN  Female   \n",
       "801                  LIVING           NaN       Positive          NaN  Female   \n",
       "802                  LIVING           NaN       Negative          NaN  Female   \n",
       "803                  LIVING           NaN       Negative          NaN  Female   \n",
       "804                  LIVING           NaN       Positive          NaN  Female   \n",
       "805                  LIVING           NaN       Positive          NaN  Female   \n",
       "806                  LIVING           NaN       Positive          NaN  Female   \n",
       "807                  LIVING           NaN       Negative          NaN  Female   \n",
       "808                  LIVING           NaN       Positive          NaN  Female   \n",
       "809                  LIVING           NaN       Negative          NaN  Female   \n",
       "810                  LIVING           NaN       Negative          NaN  Female   \n",
       "811                  LIVING           NaN       Negative          NaN  Female   \n",
       "812                  LIVING           NaN       Negative          NaN  Female   \n",
       "813                  LIVING           NaN       Negative          NaN  Female   \n",
       "814                  LIVING           NaN       Positive          NaN  Female   \n",
       "815                  LIVING           NaN       Positive          NaN  Female   \n",
       "816                  LIVING           NaN       Positive          NaN  Female   \n",
       "817                  LIVING           NaN       Positive          NaN  Female   \n",
       "818                     NaN           NaN            NaN          NaN     NaN   \n",
       "819                     NaN           NaN            NaN          NaN     NaN   \n",
       "820                     NaN           NaN            NaN          NaN     NaN   \n",
       "821                     NaN           NaN            NaN          NaN     NaN   \n",
       "822                     NaN           NaN            NaN          NaN     NaN   \n",
       "823                     NaN           NaN            NaN          NaN     NaN   \n",
       "824                     NaN           NaN            NaN          NaN     NaN   \n",
       "\n",
       "     SigClust Intrinsic mRNA  SigClust Unsupervised mRNA Survival Data Form  \\\n",
       "0                      -13.0                         0.0           followup   \n",
       "1                      -13.0                         0.0           followup   \n",
       "2                      -13.0                        -6.0           followup   \n",
       "3                      -13.0                       -12.0           followup   \n",
       "4                      -13.0                         0.0         enrollment   \n",
       "5                      -13.0                         0.0           followup   \n",
       "6                      -13.0                       -12.0         enrollment   \n",
       "7                      -13.0                         0.0           followup   \n",
       "8                      -13.0                       -12.0         enrollment   \n",
       "9                      -13.0                       -12.0         enrollment   \n",
       "10                     -13.0                       -12.0         enrollment   \n",
       "11                     -13.0                         0.0           followup   \n",
       "12                     -13.0                         0.0           followup   \n",
       "13                     -13.0                       -12.0           followup   \n",
       "14                     -13.0                         0.0           followup   \n",
       "15                     -13.0                         0.0           followup   \n",
       "16                     -13.0                       -12.0           followup   \n",
       "17                     -13.0                         0.0           followup   \n",
       "18                     -13.0                       -12.0           followup   \n",
       "19                     -13.0                         0.0           followup   \n",
       "20                     -13.0                         0.0           followup   \n",
       "21                     -13.0                         0.0           followup   \n",
       "22                     -13.0                       -12.0           followup   \n",
       "23                     -13.0                         0.0           followup   \n",
       "24                     -13.0                         0.0           followup   \n",
       "25                     -13.0                       -12.0           followup   \n",
       "26                     -13.0                       -12.0           followup   \n",
       "27                     -13.0                       -12.0           followup   \n",
       "28                     -13.0                         0.0           followup   \n",
       "29                     -13.0                       -12.0           followup   \n",
       "..                       ...                         ...                ...   \n",
       "795                      NaN                         NaN         enrollment   \n",
       "796                      NaN                         NaN         enrollment   \n",
       "797                      NaN                         NaN         enrollment   \n",
       "798                      NaN                         NaN         enrollment   \n",
       "799                      NaN                         NaN         enrollment   \n",
       "800                      NaN                         NaN         enrollment   \n",
       "801                      NaN                         NaN         enrollment   \n",
       "802                      NaN                         NaN         enrollment   \n",
       "803                      NaN                         NaN         enrollment   \n",
       "804                      NaN                         NaN         enrollment   \n",
       "805                      NaN                         NaN         enrollment   \n",
       "806                      NaN                         NaN         enrollment   \n",
       "807                      NaN                         NaN         enrollment   \n",
       "808                      NaN                         NaN         enrollment   \n",
       "809                      NaN                         NaN         enrollment   \n",
       "810                      NaN                         NaN         enrollment   \n",
       "811                      NaN                         NaN         enrollment   \n",
       "812                      NaN                         NaN         enrollment   \n",
       "813                      NaN                         NaN         enrollment   \n",
       "814                      NaN                         NaN         enrollment   \n",
       "815                      NaN                         NaN         enrollment   \n",
       "816                      NaN                         NaN         enrollment   \n",
       "817                      NaN                         NaN         enrollment   \n",
       "818                      NaN                         NaN                NaN   \n",
       "819                      NaN                         NaN                NaN   \n",
       "820                      NaN                         NaN                NaN   \n",
       "821                      NaN                         NaN                NaN   \n",
       "822                      NaN                         NaN                NaN   \n",
       "823                      NaN                         NaN                NaN   \n",
       "824                      NaN                         NaN                NaN   \n",
       "\n",
       "    Tumor Stage Tumor--T1 Coded  \n",
       "0            T3         T_Other  \n",
       "1            T2         T_Other  \n",
       "2            T2         T_Other  \n",
       "3            T2         T_Other  \n",
       "4            T1              T1  \n",
       "5            T3         T_Other  \n",
       "6            T1              T1  \n",
       "7            T1              T1  \n",
       "8            T2         T_Other  \n",
       "9            T2         T_Other  \n",
       "10           T1              T1  \n",
       "11           T2         T_Other  \n",
       "12           T3         T_Other  \n",
       "13           T2         T_Other  \n",
       "14           T2         T_Other  \n",
       "15           T1              T1  \n",
       "16           T1              T1  \n",
       "17           T2         T_Other  \n",
       "18           T2         T_Other  \n",
       "19           T2         T_Other  \n",
       "20           T3         T_Other  \n",
       "21           T2         T_Other  \n",
       "22           T2         T_Other  \n",
       "23           T1              T1  \n",
       "24           T2         T_Other  \n",
       "25           T2         T_Other  \n",
       "26           T3         T_Other  \n",
       "27           T2         T_Other  \n",
       "28           T2         T_Other  \n",
       "29           T2         T_Other  \n",
       "..          ...             ...  \n",
       "795          T2         T_Other  \n",
       "796          T2         T_Other  \n",
       "797          T3         T_Other  \n",
       "798          T1              T1  \n",
       "799          T1              T1  \n",
       "800          T1              T1  \n",
       "801          T2         T_Other  \n",
       "802          T1              T1  \n",
       "803         NaN             NaN  \n",
       "804         NaN             NaN  \n",
       "805         NaN             NaN  \n",
       "806         NaN             NaN  \n",
       "807         NaN             NaN  \n",
       "808         NaN             NaN  \n",
       "809         NaN             NaN  \n",
       "810         NaN             NaN  \n",
       "811         NaN             NaN  \n",
       "812         NaN             NaN  \n",
       "813         NaN             NaN  \n",
       "814         NaN             NaN  \n",
       "815         NaN             NaN  \n",
       "816         NaN             NaN  \n",
       "817         NaN             NaN  \n",
       "818         NaN             NaN  \n",
       "819         NaN             NaN  \n",
       "820         NaN             NaN  \n",
       "821         NaN             NaN  \n",
       "822         NaN             NaN  \n",
       "823         NaN             NaN  \n",
       "824         NaN             NaN  \n",
       "\n",
       "[825 rows x 31 columns]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "clinical = pd.read_csv('data/brca_tcga_pub_clinical_data.tsv', sep='\\t')\n",
    "\n",
    "with pd.option_context('display.max_columns', None):\n",
    "    display(clinical)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "To make the later survival analysis easier, we create two new columns, one for the survival in days, and one for the event (death) beign present."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "clinical['Time'] = clinical['Overall Survival (Months)']*30\n",
    "clinical['Event'] = (clinical['Overall Survival Status'] == 'DECEASED')*1"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Lets plot how the survival data looks like"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Text(0.5,0,'Days alive')"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fa4608975c0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "matplotlib.rcParams['figure.figsize'] = [15, 50]\n",
    "\n",
    "data_sorted = clinical[['Time','Event']].sort_values(by = 'Time').dropna().reset_index(drop=True)\n",
    "status_slice = data_sorted['Event'] == 1\n",
    "\n",
    "plt.barh(data_sorted.loc[~status_slice].index, data_sorted.loc[~status_slice,'Time'], height = 1, color = 'b')\n",
    "plt.barh(data_sorted.loc[status_slice].index, data_sorted.loc[status_slice,'Time'], height = 1, color = 'r')\n",
    "plt.legend(['Alive', 'Dead'])\n",
    "plt.ylabel('Patients')\n",
    "plt.xlabel('Days alive')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "### Exercises\n",
    "1.1 Describe the plot and what inferences you are able to make from it\n",
    "\n",
    "---\n",
    "# Part 3 - Survival analysis using the clinical data\n",
    "\n",
    "\n",
    "\n",
    "Ok, now that we've seen the data, lets play around with it.\n",
    "\n",
    "How does the survival curve looks like in general? We can use the survival package __lifelines__ to figure this out, and generate a *Kaplan Meier plot*"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "collapsed": false,
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fa4608a65c0>"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fa4607bb080>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "kmf = lifelines.KaplanMeierFitter()\n",
    "\n",
    "clinical = clinical.dropna()\n",
    "\n",
    "kmf.fit(clinical['Time'], clinical['Event'])\n",
    "\n",
    "matplotlib.rcParams['figure.figsize'] = [15, 10]\n",
    "kmf.plot()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "### Exercises\n",
    "\n",
    "2.1 Compare the Kaplan Meier plot with the first one, what additional insights are avaliable on this latter plot?\n",
    "\n",
    "---\n",
    "\n",
    "Now we can start to play around with clinical variables that might influence in the survival curve.\n",
    "\n",
    "You should play around with the groupings and see if you can find some usefull insight"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Text(0.5,1,'Metastasis')"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA20AAAJcCAYAAABqo0x2AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADl0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uIDIuMS4yLCBodHRwOi8vbWF0cGxvdGxpYi5vcmcvNQv5yAAAIABJREFUeJzs3XuYZlV9J/rvqurqe9M03Q3KTWilCYgEmRYvHU0pE2hiJsTJiWASExMTkoyex2QcYpuTR6Mz43FmcqLHy2CMGBPHM8J4oocxCF4mznjDodEew0UFaS4NKk030PSluuuyzh9vgUXTl+qqt2rvqvp8nud93tr7XXutX1VvuvrL2nvtUmsNAAAA7dTTdAEAAAAcmtAGAADQYkIbAABAiwltAAAALSa0AQAAtJjQBgAA0GJCGwB0WSllVyllTdN1ADA7CG0ANKaUck8pZX8pZdUB+79dSqmllNOOcHx/KWVrl2r5WCnl33Sjr1rr0lrr3d3oCwCENgCatiXJa57YKKU8L8ni5soBgHYR2gBo2seT/MaY7d9M8rdPbJRSFpRS/ryUcl8p5cellA+VUhaVUpYk+VySE0cvR9xVSjmxlHJBKeUbpZRHSyk/LKV8oJQyf7SvUkp5TynloVLKzlLKP5ZSzimlXJHk15L88Wg//3W0/cZSyg9KKY+XUm4vpbxqTF3PKaX891LKY6WUh0sp14z5rJZSnjP69c+PHvt4KeWBUsq/msKfJQCzkNAGQNNuSnJMKeWsUkpvksuT/Kcxn787ydok5yV5TpKTkryt1ro7ySVJHhy9HHFprfXBJMNJ/ijJqiQvTnJhkn8x2tdFSV422t/yJK9Osr3W+uEkn0jy70f7+Wej7X+Q5KWjbd+R5D+VUp45+tm/TvL5JCuSnJzk/Yf4/q5O8nu11mVJzkny3ybwMwJgDhPaAGiDJ2bbfi7JHUkeGN1fklyR5I9qrTtqrY8neVc6we6gaq231FpvqrUO1VrvSfKXSX529OPBJMuS/FSSUmu9o9b6w8P09V9qrQ/WWkdqrdckuTPJBWP6elaSE2utA7XWrx6im8EkZ5dSjqm1PlJr/dYRfhYA8BRCGwBt8PEkv5rkdRlzaWSS1enc33bL6OWOjya5YXT/QZVS1pZSPltK+VEpZWc6IW9VktRa/1uSDyT5YJKHSikfLqUcc5i+fqOUsnnM2Oc80VeSP04nVP7PUsptpZTfPkQ3v5zk55PcO3o55YsP/6MAgKcS2gBoXK313nQWJPn5JH835qOHk+xN8txa67Gjr+W11qVPHHqQ7q5K8t0kZ9Raj0nyJ+mEqyfGel+t9Z8kOTudyySvPFhfpZRnJfmrJG9MsrLWemySW5/oq9b6o1rr79ZaT0zye0n+4xP3sR3wvd1ca700yfFJPpPk2vH+XAAgEdoAaI/XJ3nF6L1qTxhJJzi9p5RyfJKUUk4qpVw8+vmPk6wspSwfc8yyJDuT7Cql/FSSP3jig1LKC0opLyyl9CXZnWRgdIwn+hr7bLUl6QS5baPH/lY6M21P9PUrpZSTRzcfGW07Mub4lFLml1J+rZSyvNY6OFrXU9oAwJEIbQC0Qq31B7XWTQf56C1J7kpy0+jljl9McuboMd9N8p+T3D16CeOJSf5VOpdaPp5O4LtmTF/HjO57JMm9SbYn+Q+jn12dzr1nj5ZSPlNrvT3J/5XkG+kEuucl+dqYvl6Q5JullF1JrkvypkM8m+21Se4Zrf3301mlEgDGrdR6sCtLAAAAaAMzbQAAAC0mtAEAALSY0AYAANBiQhsAAECLzWtq4FWrVtXTTjutqeEBAAAadcsttzxca119pHaNhbbTTjstmzYdbGVnAACA2a+Ucu942rk8EgAAoMWENgAAgBYT2gAAAFqssXvaAACAmWFwcDBbt27NwMBA06XMSAsXLszJJ5+cvr6+CR0vtAEAAIe1devWLFu2LKeddlpKKU2XM6PUWrN9+/Zs3bo1p59++oT6cHkkAABwWAMDA1m5cqXANgGllKxcuXJSs5RCGwAAcEQC28RN9mcntAEAALSY0AYAALReb29vzjvvvJxzzjn5lV/5lezZs+eo+/id3/md3H777UmSd73rXU/57CUveUlX6pwKQhsAANB6ixYtyubNm3Prrbdm/vz5+dCHPnTUfXzkIx/J2WefneTpoe3rX/96V+qcCkIbAAAwo7z0pS/NXXfdlST5i7/4i5xzzjk555xz8t73vjdJsnv37rzyla/MT//0T+ecc87JNddckyTp7+/Ppk2bsnHjxuzduzfnnXdefu3Xfi1JsnTp0iTJ5Zdfnr//+79/cqzXve51+dSnPpXh4eFceeWVecELXpBzzz03f/mXfzlt368l/wEAgHF7x3+9Lbc/uLOrfZ594jF5+z977rjaDg0N5XOf+1w2bNiQW265JX/913+db37zm6m15oUvfGF+9md/NnfffXdOPPHEJ8PXY4899pQ+3v3ud+cDH/hANm/e/LT+L7vsslx77bV55Stfmf379+dLX/pSrrrqqlx99dVZvnx5br755uzbty/r16/PRRddNOFl/I+GmTYAAKD1npgZW7duXU499dS8/vWvz1e/+tW86lWvypIlS7J06dL883/+z/OVr3wlz3ve8/KFL3whb3nLW/KVr3wly5cvH/c4l1xySf7hH/4h+/bty+c+97m87GUvy6JFi/L5z38+f/u3f5vzzjsvL3zhC7N9+/bceeedU/gd/4SZNgAAYNzGOyPWbU/c0zYea9euzbe+9a1cf/31+dM//dNceOGFedvb3jauYxcuXJj+/v7ceOONueaaa3L55Zcn6Twk+/3vf38uvvjiCX8PE2WmDQAAmJFe+tKX5jOf+Uz27NmT3bt359Of/nRe+tKX5sEHH8zixYvz67/+67nyyivzrW9962nH9vX1ZXBw8KD9XnbZZfnrv/7rfOUrX8mGDRuSJBdffHGuuuqqJ4/5/ve/n927d0/dNzeGmTYAAGBGOv/88/O6170uF1xwQZLOkv7Pf/7zc+ONN+bKK69MT09P+vr6ctVVVz3t2CuuuCLnnntuzj///HziE594ymcXXXRRXvva1+bSSy/N/Pnzn+z7nnvuyfnnn59aa1avXp3PfOYzU/9NJim11mkZ6EDr1q2rmzZtamRsAABg/O64446cddZZTZcxox3sZ1hKuaXWuu5Ix7o8EgAAoMWENgAAgBYT2gAAAFrsiKGtlPLRUspDpZRbD/F5KaW8r5RyVynlO6WU87tfJgAAwNw0npm2jyXZcJjPL0lyxujriiRPX5oFAACACTnikv+11v9RSjntME0uTfK3tbMM5U2llGNLKc+stf6wSzVOm5v+4+9m2aN3dL3fry16eb60+OfH1fbS807Kr77w1K7XAAAAzEzduKftpCT3j9neOrrvaUopV5RSNpVSNm3btq0LQ7ffaYN3Z/3uLyTDg0kdPvQrNbf/cGf+v80PNF0yAAC0Tiklb37zm5/c/vM///P82Z/9WdfHede73vWU7Ze85CVdH+NoTevDtWutH07y4aTznLbpHHs8XvQv/qr7nX50Q567e3uu+ZkfJz2HyMjDQ8lxa3LZf13UCXe7jhBoF688dF8AADALLViwIH/3d3+Xt771rVm1atWUjfOud70rf/Inf/Lk9te//vUpG2u8uhHaHkhyypjtk0f38YSd9ydfe++hP68jyUnrkoGLOttb/seh2w7vT059YbJg+cTrWXRs0tM78eMBAGCazZs3L1dccUXe85735N/+23/7lM+2bduW3//93899992XJHnve9+b9evXZ9u2bfnVX/3VPPjgg3nxi1+cL3zhC7nllluyatWq/NIv/VLuv//+DAwM5E1velOuuOKKbNy4MXv37s15552X5z73ufnEJz6RpUuXZteuXbn88svz2te+Nq985SuTJK973evyC7/wC3nVq16VjRs35stf/nL27duXN7zhDfm93/u97n7vXejjuiRvLKV8MskLkzw2E+9nmzLPfVWyZ8fh2zxyb1J6kt7OCZClxx667Z4dyQPfSlImVs/Q3uQ5P5csWjGx40tJevsmdiwAADPf5zYmP/rH7vb5jOcll7z7iM3e8IY35Nxzz80f//EfP2X/m970pvzRH/1RfuZnfib33XdfLr744txxxx15xzvekVe84hV561vfmhtuuCFXX331k8d89KMfzXHHHZe9e/fmBS94QX75l3857373u/OBD3wgmzdvftrYl112Wa699tq88pWvzP79+/OlL30pV111Va6++uosX748N998c/bt25f169fnoosuyumnnz75n8uoI4a2Usp/TtKfZFUpZWuStyfpS5Ja64eSXJ/k55PclWRPkt/qWnWzwfN/vXM549ITDt3mho3Jji15W33H6PZhLn1c05+sPdxinkewe1tyz1cmfnzpSZ5zYbJwEjN9AAAwAcccc0x+4zd+I+973/uyaNGiJ/d/8YtfzO233/7k9s6dO7Nr16589atfzac//ekkyYYNG7JixU8mLt73vvc9+dn999+fO++8MytXrjzk2Jdcckne9KY3Zd++fbnhhhvyspe9LIsWLcrnP//5fOc738mnPvWpJMljjz2WO++8c3pDW631NUf4vCZ5Q9cqmovW9Hfet48cvt2OLZ33yYS2JasnfmySPP7D5Ee3Jn2LO5N9xz07WXjM5PoEAGDmGMeM2FT6wz/8w5x//vn5rd/6yVzRyMhIbrrppixcuHBcfXz5y1/OF7/4xXzjG9/I4sWL09/fn4GBgcMes3DhwvT39+fGG2/MNddck8svvzxJUmvN+9///lx88cUT/6aOYFoXIuEQ1m5I1m7IO6/bnV37hvInzxk8aLNz/vH/zJKHf5Ddn37zQT9/Qk9PybIFh/ijXdM/udC38NjRyz13JHu2d2bc5i0Yx4ElmTd/4uMCAECS4447Lq9+9atz9dVX57d/+7eTJBdddFHe//7358orr0ySbN68Oeedd17Wr1+fa6+9Nm95y1vy+c9/Po888kiSzmzYihUrsnjx4nz3u9/NTTfd9GT/fX19GRwcTF/f028Juuyyy/KRj3wkmzZtysc+9rEkycUXX5yrrroqr3jFK9LX15fvf//7Oemkk7JkyZKufc9CW8uMjNQcu/jg4Wb3ST+TeT/6+hH/0IaGDzFj142Zur5FnVfSWUDl/v+Z9IzjNOqZ17mscsGyiY8NAABJ3vzmN+cDH/jAk9vve9/7nrzfbWhoKC972cvyoQ99KG9/+9vzmte8Jh//+Mfz4he/OM94xjOybNmybNiwIR/60Idy1lln5cwzz8yLXvSiJ/u64oorcu655+b888/PJz7xiaeMe9FFF+W1r31tLr300syf3/k3++/8zu/knnvuyfnnn59aa1avXp3PfOYzXf1+S+fqxum3bt26umnTpkbGnlb7dyff+9zh72kbddl1u7Nz72D+/KWTW87/0T37s/45B1kG9YaNnfcNDUxp7/pR8szzkgVHeSnlwmN+EhIBAGjEHXfckbPOOqvpMo7avn370tvbm3nz5uUb3/hG/uAP/uCgi4xMh4P9DEspt9Ra1x3pWDNtc82OLT8JbxOxpn9iM3W9C5IffufojhkaSE5+QbJ67dGPBwDAnHfffffl1a9+dUZGRjJ//vz81V9NwXOZp4HQNpes6Z/c8ZO5vHIijxjY/XCy7/Hk0fuO/tgjWXisBVQAAGa5M844I9/+9rebLmPShLa5ZHTBkwkbfTTBkzN1a/on19+RLFiaPLKl8+qmwb3JSecnC5/b3X4BAGaxWmtKmeCzgue4yd6SJrRNuZIMD3ZeM/2h1Gv6f/J1NxY1OZJ5C5Ol41u29ajs2dGZwTvYQ8/HLrQCAECSznL327dvz8qVKwW3o1Rrzfbt28f9OIKDEdqmWt+iZMnKzuzO4U7wMrnFR6bF2Jm6ydwX17S+hZ1LLnc+8NT9+3cnz3hecuLzm6kLAKClTj755GzdujXbtm1rupQZaeHChTn55JMnfLzQNtVKSZY9M3nk3k4oOJg6kgztSzLDlsM/mkVN1vRP7azc0ehb3HkdqPexpKHVVAEA2qyvry+nn35602XMWULbdHjG8zqvQ9n9cHL3l6etnK5Y0z/+ttNxKWU3lJ7k4Ts7ATvpPDR87cVJT2+zdQEAMKcJbW0xet9bGRlM396dh2lYM7jguPE90HoqHc2iJgcuYHI01vRPX9hbsCyZP+bJ9bu3dWZBI7QBANAcoa0NFi5P1vxs8vU7MzS8P4+fcOYhmy7Zfmt6hvdnpOnQdjTW9E/suCZm6A68t/DR+7p3v+GiFcmiY7vTFwAAc8YM+pf/LNbblxxzYtJ7b0Z6avYvfsYhmy7cuSU9g3unsbgumOijBppe7KR3fvLg5u70tW9n5zEDQhsAAEdJaJtxSubt35GR4UMsapJk/r7BZNfIwT+sI53gMG8KltKfChO9rPJI1vQfOUhO5IHghzLTH/cAAEBjhLYZZtfK56Xn2LWHbbN9175kzTMP/uGPb+08o2wmhLY1/VPTb1MLo+z8UWcl0aXHT++4AADMaELbDDPStyQjfUsO22b/4EDn2XAHs2BZJ7TNBBO9rPJImrjscsExyeM/SvY+KrQBAHBUhLa5aGjfoZ8Zd0Sl88Dwwz0onKfr6U3mzW+6CgAAZiChba5ZvDLZt2vix+/ZnmQkmb+0ayU14lD3yq3pn8LLJkuy7budFSlnk96+5JQLOmEeAICuE9rmmhXP6rwm6t5vdC7xm8nW9B98/1Tf67b4uGRof1Lr1PTflF0PJcP7hTYAgCkitM1CA0PDuW7zA1PS94rt29K3f2eG5w0css3iBfPy/FNavLT9oe6Vm+p73UpP0jcDFoA5Wvu79Bw7AAAOSmibhU5ZcfiFSiZj2Z6+LBgeyPC83iTJ8LzFyQEP+n50z/4pG3/Kjb1sck3/9K8wCQAAB/C/yDkq+5acmL3HPCv7Fx2f2tObefsfa7qk7lnTnxx3eufrHVuSu7/cYDEzyMhw8tAdyeChZ18BAJg4M20clf1LT87+pScnSRY+9oMsfuS7DVfURWMvm2zisQAz1cLlycPfT1atnZ2XfwIANMxMGzA5fYuTIzw7EACAiTPTxqT07Xs0pY48Zd+CfYPJruEDWpbO4wZ6eqevuMk61GMBJmpNv3vkAAA4akIbE7Z/8Ql55KT+p+1/ZPdAcsoznrrz4TuToYFk/gyZkVnT393+pvpxAgAAzFpCGxM20rc0+/ue/pDtvXUgOfakp+589N5keHCaKuuCQz0WYKJm+z1yI8PJvV9LUibeR29fcuqLk4XHdK0sAIDZQGgDJm/ZCckBl8ketT0PJyND3akHAGAWEdqYHrUme7Yng3uP7rj5S2fPioQ/vjX5/g2z8xLJ0tN5TbYPAACeRmhjeqw6M1lyQlKO4vK5fbuSR7bMjtC2pr8T2u7+8uwMbQAATBmhjemx7ITO62g89kAntM0Gazd4WDcAABPieiSgPQb3di6lBQDgSUIb7VZrZ4GLrr8Eg9Ypvcn930z272q6EgCAVnF5JO3VO7+zDPyeHV3uuHZC29Lju9zvOHT7gd1tsKa/O/fpLV6Z7HpIoAYAOIDQRnstXZ0899Lu9/v4j5J7vtb9fo9kTf/0jznVPDQcAGDKCW0wXbr9wO42mG2zhgAALeSeNgAAgBYT2gAAAFrM5ZEt88Cje/POz942qT7WP3tVLjzrKJ+JNtcMDSS7H3rqvpGRZN78ZNFxzdREUoeTOz9/dMcsPCZ5zs8d3YPbAQBmEKGtRS4976Rs37VvUn3cu31PkoeFtsNZcnxy1i88ff/uh5MHvz399fATy5559KtH7h5dcVJoAwBmKaGtRX71hadm6YLerF62cMJ9THaWbk7o6UkWLn/6/uHB6a9lNvjxrcn3b+jeIivCFwDAU7inDZi4Nf2d97u/3GARAACzm9AGTNzaDckJ5zRdBQDArObySBhr/+5k149HN0qyZLXL9QAAaJTQBk9YuDxZe/FPFsK4/5ud1QyL/0xab9/OyYXr+cs69zoCALSQf43CE3r7kmXP+Ml2j/88ZoSRkeSuL078+DrSuTdv6fHdqggAoKv8q5SuGxgaznWbH5i28ZYt6svLz/QP7jnrmGdO7vhdDx39YwYAAKaR0EbXnbJiybSOt+3xgWkdDwAAppPQBoezZ0dSunSv0/wlSd+i7vTVNju2JDdsnFwfa/q796w3AIBZRGiDQ3nG85L9e7rT18Cjyc4HZmdoW9M/+T52bOm8C20AAE8jtMGhrHhW9/p6/Med0DYbrd0w+bA12Vk6AIBZzBrXAAAALWamDZjb6kjy41uTbd9rupKn6u1LTnx+0rew6UoAgIYJbcDctnhlMrw/GR5supKn2rUzOeFsoQ0AENpg2gwPdl69fU1Xwli9fe38Mxnc3XQFAEBLuKcNpsP8Jcmxz0r27mi6EgAAZhihDabDgqXJilObrgIAgBlIaAMAAGgxoQ1ohx/fmnz/hqarAABoHaENaN6a/s773V9usAgAgHayeiRMp307k57Z9p9dSRYuT3p6J97F2g0C28Hsb8kKkr0LPHoAABo02/71CO21cHlyyouS1KYr6a5HtyZDA50VMume0pvc942mq0hGRpJjTkxOW990JQAwZwltMF0WLOs8LHm22bsj2deSGaHZZPHKpivoGNyTjAw1XQUAzGnuaQMAAGgxoQ0AAKDFhDYAAIAWE9oAAABazEIkQHvs2JLcsPHojlnT33lkAADALCW0Ae2wpv/oj9mxpfMutAEAs5jQBrTD2g1HH76OdlYOAGAGck8bAABAiwltABze4N5k2/eTPTuargQA5iShDYBD613QCW1bNyWP3d90NQAwJwltwOTUmgzt67wz+/T0JktWJQuWNl0JAMxZQhswOUtWJyNDyeDupisBAJiVhDZgco4/K1l+spk2AIApIrQBAAC0mOe0MeMNDA3nus0PNF3GIS1b1JeXn3l802UAADBDCW3MeKesWNJ0CYe17fGBpkuY3XZsmdxDttf0H/1DvQEAppHQBsxca/ond/yOLZ13oQ0AaDGhDZi51m6YXOCazAwdAMA0sRAJAABAiwltAAAALebySADGoSQ77kl2bWu6kNmjlOTE5yeLj2u6EgBaTmgD4MgWLk+G9yXxEPWu2b09GdzbdBUAzABCGwBHVkoyb2HTVcwuPX4FAzA+fmMAk1eS7Ns5yVmDmixakfTO71ZVAACzgtAGTN7qs5JjnzW5Prbflex9TGgDADiA0DYL3bt9T9752dsaG3/9s1flwrNOaGx8GrDwmM5rMh69rzu1AADMMkLbLLP+2auSPNzY+Pdu35PkYaGNmWPHlnY+ZHtN/+QeHA4AzBrjCm2llA1J/u8kvUk+Umt99wGfn5rkb5IcO9pmY631+i7XyjhceNYJjQamJmf44Kit6W+6goPbsaXzLrQBABlHaCul9Cb5YJKfS7I1yc2llOtqrbePafanSa6ttV5VSjk7yfVJTpuCegG6Z+2GdgajNs78AQCN6RlHmwuS3FVrvbvWuj/JJ5NcekCbmuSJG1qWJ3mweyUCAADMXeMJbScluX/M9tbRfWP9WZJfL6VsTWeW7X8/WEellCtKKZtKKZu2bds2gXIBAADmlvGEtvF4TZKP1VpPTvLzST5eSnla37XWD9da19Va161evbpLQwMAAMxe4wltDyQ5Zcz2yaP7xnp9kmuTpNb6jSQLk6zqRoEAAABz2XhC281JziilnF5KmZ/k8iTXHdDmviQXJkkp5ax0QpvrHwEAACbpiKGt1jqU5I1JbkxyRzqrRN5WSnlnKeUXR5u9OcnvllL+V5L/nOR1tdY6VUUDAADMFeN6TtvoM9euP2Df28Z8fXuS9d0tDQBms5o8+O3kR99puhDGpSQn/ZNkqXvygek3rtAGAHTZktXJyFDTVTBeux9OhgaargKYo4Q2AGhC6Ul65zddBePV09t0BcAc1q0l/wEAAJgCZtqAdig9yb6dSd+ipLev6Wqat2NLcsPGpqvoWNOfrN3QdBUAMGcJbUA7rP6pZOCxZHhQaFvT33QFP7FjS+ddaAOAxghtQDssWJr09CXDFmbI2g3tCUltme0DgDnMPW0AAAAtJrQBAAC0mNAGAADQYkIbAABAiwltAAAALSa0AQAAtJjQBgAA0GJCGwAAQIsJbQAAAC0mtAEAALSY0AYAANBi85ouAOApRoaS4cHxty89SU/v1NUDANAwoQ1oj8Urkn07k8E94z9m4LFk+SlJKVNXF0BK8sP/lfz41qYLGZ9jT0tOOKvpKoAuEdpgig0MDee6zQ80MvayRX15+ZnHNzL2hDzjeZ3X0bj100lqEqENmEJLVnWuBJgJ9u9J9u5ougqgi4Q2mGKnrFjS2NjbHh9obGxmkR1bkhs2Jmv6k7Ubmq4GmlF6kt75TVcxPr37m64A6DKhDYBDW9Pfed+xpfMutAHAtLN6JACHtnZDsuHdyXGnN10JAMxZQhsAAECLCW0AAAAtJrQBAAC0mNAGAADQYkIbAABAiwltAAAALSa0AQAAtJjQBgAA0GJCGwAAQIvNa7oAgEnb9dDkjl98XNI7vzu1AAB0mdAGzGynvigZ3j/x43f+MNn9ULJIaAMA2kloA2a2Y545ueMHdia7u1MKAMBUcE8bAABAiwltAAAALSa0AQAAtJh72gAYnx1bkhs2Nl3F7LGmP1m7oekqAJgBhDa67t7te/LOz942beOtf/aqXHjWCdM2HsxJa/qbrmB22bGl8y60ATAOQhtdtf7Zq5I8PG3j3bt9T5KHhTaYams3CBjdZMYSgKMgtNFVF551wrQGqOmc0QOAGWN4f7LzwaargPbomZcsPb7pKiZMaAMAmE16FyS7tyd7vt50JdAepSRnvyrpmZnrMAptAACzSW9fssxtA/AUu37cdAWTMjOjJgAAwBwhtAEAALSY0AYAANBi7mkDGBnqrLTWNr3zm64AAGgBoQ2Y2xYsS/qWJMNDTVfyVPt3JguOSfoWN10JANAwoQ2Y2447rfNqm3u+kuzb3XQVAEALuKcNAACgxYQ2AACAFhPaAAAAWkxoAwAAaDGhDQAAoMWENgAAgBYT2gD+U/KTAAAYM0lEQVQAAFpMaAMAAGgxoQ0AAKDFhDYAAIAWE9oAAABaTGgDAABoMaENAACgxeY1XQAAzEk7tiQ3bGy6CsZrTX+ydkPTVQBzlNAGANNtTX/TFXA0dmzpvAttQEOENoC2GhlKhgebriIpPUlPb9NVzC5rNwgAM4kZUaBhQhtAGy1ckezblQzva7aOOtKp45gTm60DAOYwoQ1msYGh4Vy3+YGmy2BCVoy+mtU7uDvH//i/Z/+C+U2XAo05Z+9genpKljVdCDBnCW0wi52yYknTJTDD9QwOZfljfRlcJLQxd83r7cnQ8EjTZQBzmCX/AQAAWkxoAwAAaDGhDQAAoMWENgAAgBYT2gAAAFpMaAMAAGgxoQ0AAKDFhDYAAIAWE9oAAABaTGgDAABoMaENAACgxYQ2AACAFhPaAAAAWkxoAwAAaDGhDQAAoMWENgAAgBYT2gAAAFpMaAMAAGgxoQ0AAKDFhDYAAIAWm9d0ATBZ927fk3d+9ramyzik9c9elQvPOqHpMgAAmKHGNdNWStlQSvleKeWuUsrGQ7R5dSnl9lLKbaWU/6e7ZcLBrX/2qjxr5eKmyzike7fvydd+8HDTZQAAMIMdcaatlNKb5INJfi7J1iQ3l1Kuq7XePqbNGUnemmR9rfWRUsrxU1UwjHXhWSe0eharzTOAAADMDOOZabsgyV211rtrrfuTfDLJpQe0+d0kH6y1PpIktdaHulsmAE2pSfr2bkvv/seaLgUA5qTxhLaTktw/Znvr6L6x1iZZW0r5WinlplLKhoN1VEq5opSyqZSyadu2bROrGIBpMzJvSR478WXZterc9AwPNl0OAMxJ3Vo9cl6SM5L0J3lNkr8qpRx7YKNa64drretqretWr17dpaEBmDKlZHjB8ozMa++9owAw241n9cgHkpwyZvvk0X1jbU3yzVrrYJItpZTvpxPibu5KlQAADVqy+77khoOuxdZOa/qTtQe98AmYgcYz03ZzkjNKKaeXUuYnuTzJdQe0+Uw6s2wppaxK53LJu7tYJwBAIx57xkuye8mpTZcxfju2JHd/uekqgC464kxbrXWolPLGJDcm6U3y0VrrbaWUdybZVGu9bvSzi0optycZTnJlrXX7VBYOADAdHjn5wmw57qVZ/5xVTZcyPjNpRhAYl3E9XLvWen2S6w/Y97YxX9ck/3L0BQAAQJd0ayESAAAApoDQBgAA0GJCGwAAQIsJbQAAAC0mtAEAALSY0AYAANBiQhsAAECLCW0AAAAtJrQBAAC0mNAGAADQYkIbAABAiwltAAAALSa0AQAAtJjQBgAA0GJCGwAAQIsJbQAAAC0mtAEAALTYvKYLAKD9aulNLcm8vduaLmXWKBnJSO/CDM9f3nQpALSc0AbAEQ0tPC47Tr2k6TJmlYU7787iR7/fdBkAzABCGwDj09PbdAWzS3GHAgDj4zcGAABAiwltAAAALSa0AQAAtJjQBgAA0GJCGwAAQIsJbQAAAC0mtAEAALSY0AYAANBiQhsAAECLCW0AAAAtJrQBAAC0mNAGAADQYkIbAABAi81rugAAALpsx5bkho1NVwHNOm5NcsEVTVfRFUIbAMBssqa/6QqALhPaAABmk7UbOi9g1nBPGwAAQIsJbQAAAC0mtAEAALSYe9paZtmivmx7fGBSfQwMDeeUFUu6VBEAANAkoa1lXn7m8ZPu47rND3ShEgAAoA1cHgkAANBiQhsAAECLCW0AAAAtJrQBAAC0mNAGAADQYkIbAABAiwltAAAALSa0AQAAtJiHa8MUu3f7nrzzs7c1Mvb6Z6/KhWed0MjYAAB0h9AGU2j9s1clebiRse/dvifJw0IbAMAMJ7TBFLrwrBMaC01Nze4BANBd7mkDAABoMTNtANCQnuGB9O7f2XQZjMO8wf3J8PKkt6/pUoA5SGgDgAYMzT82e5ef0XQZjNPg0KPJ3keSpcc3XQowBwltANCAoUUrM7RoZdNlME4Dg99L8sOmywDmKPe0AQAAtJjQBgAA0GJCGwAAQIsJbQAAAC0mtAEAALSY0AYAANBiQhsAAECLCW0AAAAtJrQBAAC0mNAGAADQYkIbAABAiwltAAAALSa0AQAAtJjQBgAA0GJCGwAAQIsJbQAAAC0mtAEAALSY0AYAANBiQhsAAECLCW0AAAAtJrQBAAC0mNAGAADQYkIbAABAiwltAAAALSa0AQAAtNi8pgug+5Yt6su2xwcaG39gaDinrFjS2PgAADCbCG2z0MvPPL7R8a/b/ECj4wMAwGzi8kgAAIAWE9oAAABaTGgDAABoMaENAACgxYQ2AACAFhPaAAAAWmxcoa2UsqGU8r1Syl2llI2HaffLpZRaSlnXvRIBAADmriOGtlJKb5IPJrkkydlJXlNKOfsg7ZYleVOSb3a7SAAAgLlqPDNtFyS5q9Z6d611f5JPJrn0IO3+dZJ/l2Sgi/UBAADMaeMJbScluX/M9tbRfU8qpZyf5JRa698frqNSyhWllE2llE3btm076mIBAADmmkkvRFJK6UnyF0nefKS2tdYP11rX1VrXrV69erJDAwAAzHrjCW0PJDllzPbJo/uesCzJOUm+XEq5J8mLklxnMRIAAIDJG09ouznJGaWU00sp85NcnuS6Jz6stT5Wa11Vaz2t1npakpuS/GKtddOUVAwAADCHHDG01VqHkrwxyY1J7khyba31tlLKO0spvzjVBQIAAMxl88bTqNZ6fZLrD9j3tkO07Z98WQAAACRdWIgEAACAqTOumTYAgDlvZDgZmiGPo+3pS3p6m64C6BKhDQDgCIZ7FyWLj01Smy7lyGpNdj2UHPPMpisBukRoAwA4gn2Ljk/OeH7TZYzP3keTu77UdBVAF7mnDQAAoMWENgAAgBYT2gAAAFpMaAMAAGgxoQ0AAKDFhDYAAIAWE9oAAABazHPaYBa7d/uevPOztzVdBsCMd+5Jy/OL553UdBnAHCW0wSy1/tmrkjzcdBkAM9692/dkcGik6TKAOUxog1nqwrNOyIVnndB0GQAz3js/e5vQBjTKPW0AAAAtJrQBAAC0mNAGAADQYkIbAABAiwltAAAALSa0AQAAtJjQBgAA0GJCGwAAQIsJbQAAAC0mtAEAALSY0AYAANBi85ougNln2aK+bHt8YNrGGxgazikrlkzbeAAAMJ2ENrru5WceP63jXbf5gWkdDwAAppPLIwEAAFpMaAMAAGgxoQ0AAKDFhDYAAIAWE9oAAABaTGgDAABoMaENAACgxYQ2AACAFhPaAAAAWkxoAwAAaDGhDQAAoMWENgAAgBYT2gAAAFpMaAMAAGgxoQ0AAKDFhDYAAIAWE9oAAABaTGgDAABoMaENAACgxeY1XQAAAF1WR5LhwaarALpEaAMAmE16+5KFy5OhvU1XAu2xZHVSStNVTJjQBgAwm8xfkqy9qOkqgC5yTxsAAECLCW0AAAAtJrQBAAC0mNAGAADQYkIbAABAiwltAAAALSa0AQAAtJjQBgAA0GJCGwAAQIsJbQAAAC0mtAEAALSY0AYAANBiQhsAAECLCW0AAAAtJrQBAAC0mNAGAADQYvOaLgAma9mivmx7fKDpMg5pYGg4p6xY0nQZAADMUEIbM97Lzzy+6RIO67rNDzRdAgAAM5jLIwEAAFpMaAMAAGgxoQ0AAKDFhDYAAIAWE9oAAABaTGgDAABoMaENAACgxYQ2AACAFhPaAAAAWkxoAwAAaDGhDQAAoMWENgAAgBYT2gAAAFpMaAMAAGgxoQ0AAKDFhDYAAIAWE9oAAABaTGgDAABoMaENAACgxYQ2AACAFhPaAAAAWkxoAwAAaDGhDQAAoMXGFdpKKRtKKd8rpdxVStl4kM//ZSnl9lLKd0opXyqlPKv7pQIAAMw9RwxtpZTeJB9MckmSs5O8ppRy9gHNvp1kXa313CSfSvLvu10oAADAXDSembYLktxVa7271ro/ySeTXDq2Qa31H2qte0Y3b0pycnfLBAAAmJvGE9pOSnL/mO2to/sO5fVJPnewD0opV5RSNpVSNm3btm38VQIAAMxRXV2IpJTy60nWJfkPB/u81vrhWuu6Wuu61atXd3NoAACAWWneONo8kOSUMdsnj+57ilLKP03yfyT52Vrrvu6UBwAAMLeNZ6bt5iRnlFJOL6XMT3J5kuvGNiilPD/JXyb5xVrrQ90vEwAAYG46YmirtQ4leWOSG5PckeTaWuttpZR3llJ+cbTZf0iyNMl/KaVsLqVcd4juAAAAOArjuTwytdbrk1x/wL63jfn6n3a5LgAAANLlhUgAAADoLqENAACgxYQ2AACAFhPaAAAAWkxoAwAAaDGhDQAAoMWENgAAgBYT2gAAAFpMaAMAAGgxoQ0AAKDFhDYAAIAWE9oAAABabF7TBcBst2xRX7Y9PtDI2ANDwzllxZJGxgYAoDuENphiLz/z+MbGvm7zA42NDQBAd7g8EgAAoMWENgAAgBYT2gAAAFpMaAMAAGgxoQ0AAKDFhDYAAIAWE9oAAABaTGgDAABoMaENAACgxYQ2AACAFhPaAAAAWkxoAwAAaDGhDQAAoMWENgAAgBYT2gAAAFpMaAMAAGgxoQ0AAKDFhDYAAIAWE9oAAABaTGgDAABoMaENAACgxYQ2AACAFhPaAAAAWkxoAwAAaDGhDQAAoMWENgAAgBYT2gAAAFpMaAMAAGgxoQ0AAKDFhDYAAIAWE9oAAABaTGgDAABoMaENAACgxYQ2AACAFpvXdAHA1Fm2qC/bHh9ougyAGW1waCQ9PaXpMoA5TGiDWezlZx7fdAkAM94nvnlfdg4MNl0GMIe5PBIAAKDFhDYAAIAWE9oAAABaTGgDAABoMaENAACgxYQ2AACAFhPaAAAAWkxoAwAAaDGhDQAAoMWENgAAgBYT2gAAAFpMaAMAAGgxoQ0AAKDFhDYAAIAWE9oAAABaTGgDAABoMaENAACgxYQ2AACAFhPaAAAAWkxoAwAAaDGhDQAAoMWENgAAgBYT2gAAAFpMaAMAAGgxoQ0AAKDFhDYAAIAWE9oAAABaTGgDAABoMaENAACgxYQ2AACAFhPaAAAAWkxoAwAAaDGhDQAAoMWENgAAgBYT2gAAAFpMaAMAAGgxoQ0AAKDFhDYAAIAWE9oAAABaTGgDAABosXGFtlLKhlLK90opd5VSNh7k8wWllGtGP/9mKeW0bhcKAAAwFx0xtJVSepN8MMklSc5O8ppSytkHNHt9kkdqrc9J8p4k/67bhQIAAMxF45lpuyDJXbXWu2ut+5N8MsmlB7S5NMnfjH79qSQXllJK98oEAACYm+aNo81JSe4fs701yQsP1abWOlRKeSzJyiQPj21USrkiyRVJcuqpp06wZACA6XP2icfkh48N5Bs/2N50KRP24mevbLoEYBLGE9q6ptb64SQfTpJ169bV6RwbAGAi3v7Pntt0CcAcN57LIx9IcsqY7ZNH9x20TSllXpLlSWbu/44CAABoifGEtpuTnFFKOb2UMj/J5UmuO6DNdUl+c/Tr/y3Jf6u1mkkDAACYpCNeHjl6j9obk9yYpDfJR2utt5VS3plkU631uiRXJ/l4KeWuJDvSCXYAAABM0rjuaau1Xp/k+gP2vW3M1wNJfqW7pQEAADCuh2sDAADQDKENAACgxYQ2AACAFhPaAAAAWkxoAwAAaDGhDQAAoMWENgAAgBYT2gAAAFpMaAMAAGgxoQ0AAKDFhDYAAIAWE9oAAABaTGgDAABoMaENAACgxYQ2AACAFhPaAAAAWkxoAwAAaDGhDQAAoMWENgAAgBYrtdZmBi5lW5J7Gxn88FYlebjpImgd5wUH47zgYJwXHMg5wcE4L0iSZ9VaVx+pUWOhra1KKZtqreuaroN2cV5wMM4LDsZ5wYGcExyM84Kj4fJIAACAFhPaAAAAWkxoe7oPN10AreS84GCcFxyM84IDOSc4GOcF4+aeNgAAgBYz0wYAANBiQhsAAECLCW1jlFI2lFK+V0q5q5Sysel6mFqllI+WUh4qpdw6Zt9xpZQvlFLuHH1fMbq/lFLeN3pufKeUcv6YY35ztP2dpZTfbOJ7oTtKKaeUUv6hlHJ7KeW2UsqbRvc7L+awUsrCUsr/LKX8r9Hz4h2j+08vpXxz9M//mlLK/NH9C0a37xr9/LQxfb11dP/3SikXN/Md0S2llN5SyrdLKZ8d3XZOzHGllHtKKf9YStlcStk0us/vECZNaBtVSulN8sEklyQ5O8lrSilnN1sVU+xjSTYcsG9jki/VWs9I8qXR7aRzXpwx+roiyVVJ5y/iJG9P8sIkFyR5+xN/GTMjDSV5c6317CQvSvKG0b8HnBdz274kr6i1/nSS85JsKKW8KMm/S/KeWutzkjyS5PWj7V+f5JHR/e8ZbZfRc+nyJM9N5++e/zj6u4eZ601J7hiz7ZwgSV5eaz1vzDPY/A5h0oS2n7ggyV211rtrrfuTfDLJpQ3XxBSqtf6PJDsO2H1pkr8Z/fpvkvzSmP1/WztuSnJsKeWZSS5O8oVa645a6yNJvpCnB0FmiFrrD2ut3xr9+vF0/jF2UpwXc9ron++u0c2+0VdN8ooknxrdf+B58cT58qkkF5ZSyuj+T9Za99VatyS5K53fPcxApZSTk7wyyUdGt0ucExyc3yFMmtD2EycluX/M9tbRfcwtJ9Rafzj69Y+SnDD69aHOD+fNLDV6+dLzk3wzzos5b/QyuM1JHkrnH1A/SPJorXVotMnYP+Mn//xHP38syco4L2ab9yb54yQjo9sr45yg8z90Pl9KuaWUcsXoPr9DmLR5TRcAbVVrraUUz8SYg0opS5P8v0n+sNa6s/M/xDucF3NTrXU4yXmllGOTfDrJTzVcEg0qpfxCkodqrbeUUvqbrodW+Zn/v517CbWqiuM4/v2ZvbDoQQ8KC0OCBlJZJJWTinLQwKAsBMkKZ6WTMHpNTAuEImhSECRF9EDDyiISQQcRhWJWvgqKDHKQZGiGEJT/BnvdvFwq7HTUc+/9fiZ777X3Xnufe9a96/73XutfVbuTnAesS/LV8J32IeqVb9oO2w1cNGx7civT+PJjG5pAW+5p5f/UPmw3Y0ySE+kCtteqanUrtl0IgKraB2wArqMbyjT08HP4d/zX99/2nwHsxXYxlswEZifZRTed4ibgOWwT415V7W7LPXQPeGZgH6I+MGg7bBNwacv8dBLdxOA1x/medOytAYayNN0DvDusfH7L9HQtsL8NdVgLzEpyVpskPKuVaRRqc0xeAnZW1bPDdtkuxrEk57Y3bCQ5FbiFbr7jBmBOO2xkuxhqL3OA9VVVrXxuyyR4CV3ygY3H5lOon6rq0aqaXFVT6P5fWF9V87BNjGtJJiU5fWid7m//NuxD1AcOj2yq6vckC+l+KU4AVlTV9uN8WzqKkrwB3ACck+QHukxNy4GVSRYA3wN3tcM/AG6lmyR+ELgPoKp+TrKMLugHWFpVI5ObaPSYCdwNbG3zlwAew3Yx3l0AvNKy+k0AVlbV+0l2AG8meRLYQhfw05avJvmGLtnRXICq2p5kJbCDLlPpA23YpcaOh7FNjGfnA2+3IfUTgder6sMkm7AP0f+U7kGPJEmSJGkQOTxSkiRJkgaYQZskSZIkDTCDNkmSJEkaYAZtkiRJkjTADNokSZIkaYAZtEmSRoUkZya5v61fmOStPtW7JMnitr40yc39qFeSpH4x5b8kaVRIMgV4v6qm9bneJcCvVfVMP+uVJKlffNMmSRotlgNTk3yeZFWSbQBJ7k3yTpJ1SXYlWZjkwSRbknya5Ox23NQkHybZnOSjJJeNvECSl5PMaeu7kjyR5LMkW4eOTzIpyYokG9s1bjuGPwNJ0jhk0CZJGi0eAb6tqiuBh0bsmwbcDlwDPAUcrKrpwCfA/HbMi8CiqroaWAw8fwTX/KmqrgJeaOcAPA6sr6oZwI3A00km9f6xJEn6dxOP9w1IktQHG6rqAHAgyX7gvVa+Fbg8yWnA9cCqJEPnnHwE9a5uy810QSHALGD20Dw44BTgYmDn//sIkiT9PYM2SdJY8Nuw9UPDtg/R9XUTgH3tLV0v9f7B4T4zwB1V9XWP9ypJ0n/i8EhJ0mhxADi9lxOr6hfguyR3AqRzRY/3sRZYlPbKLsn0HuuRJOmIGLRJkkaFqtoLfNwSkDzdQxXzgAVJvgC2A70mEFkGnAh8mWR725Yk6agx5b8kSZIkDTDftEmSJEnSADNokyRJkqQBZtAmSZIkSQPMoE2SJEmSBphBmyRJkiQNMIM2SZIkSRpgBm2SJEmSNMD+BGUBRfAaaXxRAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fa46068e080>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Define groups here\n",
    "group_1 = clinical.loc[clinical['Metastasis-Coded'] == 'Positive']\n",
    "group_2 = clinical.loc[clinical['Metastasis-Coded'] == 'Negative']\n",
    "\n",
    "kmf.fit(group_1['Time'], group_1['Event'], label='Positive')\n",
    "ax = kmf.plot()\n",
    "\n",
    "kmf.fit(group_2['Time'], group_2['Event'], label='Negative')\n",
    "kmf.plot(ax=ax)\n",
    "\n",
    "plt.title('Metastasis')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "### Exercises\n",
    "3.1 Make at least 3 plots using different separation criteria, and lable them accordingly, save them on the report.\n",
    "\n",
    "3.2 Make a plot that includes the survival curve for 3 different age groups.\n",
    "\n",
    "3.3 (Advanced) The **logrank_test** function of the **lifelines** package performs a statistical test on the two groups to see if their \"death generation process\" is the same. Use this function to obtain a significance statistic for the separations above.\n",
    "\n",
    "---\n",
    "\n",
    "# Part 4 - Cox Proportional Hazards model\n",
    "\n",
    "The next step is to use the Cox Proportional Hazards (CPH) in the data. \n",
    "\n",
    "First, let's check the main assumption of the model, the proportionality of hazards, by ploting the hazard functions on a log-log scale and seeing wether they \"look\" parallel or not."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fa454e75cc0>"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fa45e4fa780>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Define groups here\n",
    "group_1 = clinical.loc[clinical['Metastasis-Coded'] == 'Positive']\n",
    "group_2 = clinical.loc[clinical['Metastasis-Coded'] == 'Negative']\n",
    "\n",
    "kmf.fit(group_1['Time'], group_1['Event'], label='Positive')\n",
    "ax = kmf.plot_loglogs()\n",
    "\n",
    "kmf.fit(group_2['Time'], group_2['Event'], label='Negative')\n",
    "kmf.plot_loglogs(ax=ax)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "### Exercises\n",
    "\n",
    "4.1 In your oppinion, does the proportional hazards assumption hold for the Metastasis case? What about other variables you used on the previous exercise? Save the plots on your report to support your claims.\n",
    "\n",
    "---\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fa45dfde630>"
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fa45dc07d30>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "cph = lifelines.CoxPHFitter()\n",
    "\n",
    "model = 'Time + Event + Q(\"Metastasis-Coded\")'\n",
    "\n",
    "cox_input = dmatrix(model, data = clinical, return_type = 'dataframe')\n",
    "cox_input = cox_input.drop(['Intercept'], axis = 1)\n",
    "\n",
    "cph.fit(cox_input, duration_col='Time', event_col='Event')\n",
    "\n",
    "cph.plot()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Part 5 - Incorporating gene expression data\n",
    "\n",
    "It's time to look at the gene expression data!\n",
    "\n",
    "First we load the expression data for the same samples. This may take some time, be patient.\n",
    "\n",
    "We then take a look on how the data looks like. Note that the gene expression has been median normalized, so we get negative gene expression here."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "expression_raw  = pd.read_csv('data/data_expression_median.txt', sep='\\t')\n",
    "expression = expression_raw.set_index('Hugo_Symbol').iloc[:,1:].T\n",
    "expression"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Now we merge the clinical and expression data in one big datastructure, and display the result."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "data = clinical.merge(expression, how='inner', left_on='Sample ID', right_index=True)\n",
    "data"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Now we can incorporate the gene expression data into our Cox regression"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "formula = \"Q('Diagnosis Age') -1\"\n",
    "\n",
    "X = dmatrix(formula, data)\n",
    "X"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
